CPSH
CPS Technologies Corporation
CPSH trails on the overall score without a compensating advantage in the available component scores.
MSFT
Microsoft Corporation
MSFT has the edge over CPSH overall, supported by lower modeled downside and stronger fundamentals.
CPSH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Weak | |
| Strong |
CPSH's balance sheet is currently strong, and its revenue and profitability are stable, but its cash flow is weak.
MSFT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Strong |
MSFT's revenue, profitability, cash flow and balance sheet are all currently healthy.
CPSH PE Valuation
CPSH has no meaningful PE right now: it lost money over the past year.
MSFT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 25x | $523 | — |
| Cheap | 27x | $525 | +0.4% |
| Current | 27x | $523 | — |
| Fair | 34x | $652 | +25% |
| Expensive | 37x | $711 | +36% |
Historical ranges are pointers, not guarantees.
MSFT's PE is in its cheap range at 27x. If earnings grow as analysts expect, today's price would be 25x next year's earnings.
CPSH Forward outlook
There aren't enough analyst estimates for CPSH to show an outlook.
MSFT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for MSFT, with profitability holding steady.
CPSH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.00 | +$0.04 |
| Q2 2026 | -$0.01 | +$0.11 |
| Q1 2026 | $0.00 | +$0.20 |
| Q4 2025 | $0.03 | +$0.25 |
| Q3 2025 | -$0.04 | +$0.10 |
| Q2 2025 | -$0.12 | -$0.06 |
| Q1 2025 | -$0.20 | -500% |
| Q4 2024 | -$0.22 | -344% |
CPSH is still losing money, but far less than before: $0.00 per share over the past year, against $0.22 at its worst in late 2024.
MSFT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $20.79 | +8.6% |
| Q3 2026 | $19.15 | +36% |
| Q2 2026 | $17.95 | +32% |
| Q1 2026 | $16.80 | +30% |
| Q4 2025 | $15.99 | +29% |
| Q3 2025 | $14.06 | +16% |
| Q2 2025 | $13.64 | +16% |
| Q1 2025 | $12.93 | +12% |
| Q4 2024 | $12.41 | +12% |
MSFT has the edge over CPSH on earnings, with more consistent year-over-year improvement.
CPSH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $8.9M | +1.1% |
| Q2 2026 | $8.3M | +2.9% |
| Q1 2026 | $7M | -6.4% |
| Q4 2025 | $8.2M | +38% |
| Q3 2025 | $8.8M | +107% |
| Q2 2025 | $8.1M | +61% |
| Q1 2025 | $7.5M | +27% |
| Q4 2024 | $5.9M | -12% |
CPSH's revenue is growing: $9M last quarter, up 1.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4% | +0.9 points |
| Q2 2026 | -3.1% | -4.8 points |
| Q1 2026 | -7.4% | -9.2 points |
| Q4 2025 | -1.2% | +21 points |
| Q3 2025 | 3.1% | +38 points |
| Q2 2025 | 1.7% | +28 points |
| Q1 2025 | 1.7% | +6.1 points |
| Q4 2024 | -22% | -24 points |
CPSH's operating margin was 4% last quarter, up 0.9 points from the same quarter a year ago.
MSFT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $92.3B | +19% |
| Q2 2026 | $90B | +18% |
| Q1 2026 | $82.9B | +18% |
| Q4 2025 | $81.3B | +17% |
| Q3 2025 | $77.7B | +18% |
| Q2 2025 | $76.4B | +18% |
| Q1 2025 | $70.1B | +13% |
| Q4 2024 | $69.6B | +12% |
MSFT has the edge over CPSH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 50% | +0.9 points |
| Q2 2026 | 45% | +0.2 points |
| Q1 2026 | 46% | +0.7 points |
| Q4 2025 | 47% | +1.6 points |
| Q3 2025 | 49% | +2.3 points |
| Q2 2025 | 45% | +1.8 points |
| Q1 2025 | 46% | +1.1 points |
| Q4 2024 | 45% | +1.9 points |
MSFT has the edge over CPSH on profitability, with a higher operating margin.
CPSH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$310.2K | -135% |
| Q2 2026 | -$2.4M | -601% |
| Q1 2026 | -$767.8K | +$578K |
| Q4 2025 | -$494.4K | +$974.6K |
| Q3 2025 | $876.8K | +$2.1M |
| Q2 2025 | $476.4K | +$2.1M |
| Q1 2025 | -$1.3M | -$1.2M |
| Q4 2024 | -$1.5M | -3294% |
CPSH has burned cash in six of the last eight quarters: −$4M over the past year, against −$1M the year before.
MSFT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $18.6B | -27% |
| Q2 2026 | $19.6B | -23% |
| Q1 2026 | $15.8B | -22% |
| Q4 2025 | $5.9B | -9.3% |
| Q3 2025 | $25.7B | +33% |
| Q2 2025 | $25.6B | +9.6% |
| Q1 2025 | $20.3B | -3.2% |
| Q4 2024 | $6.5B | -29% |
MSFT has the edge over CPSH on cash generation, producing positive trailing cash flow while its opponent burns cash.
CPSH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -36.2x | Net Cash |
| Q1 2026 | -15.1x | Net Cash |
| Q4 2025 | -4.3x | Net Cash |
| Q1 2024 | -7.1x | Net Cash |
| Q4 2023 | -4.0x | Net Cash |
| Q3 2023 | -3.7x | Net Cash |
| Q2 2023 | -2.9x | Net Cash |
| Q1 2023 | -2.6x | Net Cash |
CPSH has the edge over MSFT on leverage, with a lower net debt burden relative to earnings.
MSFT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | 0.1x | Very low |
MSFT's net debt is less than a year of its operating earnings (EBITDA).
CPSH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.8 | Neutral |
| Stochastic | 36.9 | Neutral |
CPSH's weekly RSI is 49 (neutral) and its Stochastic is 37 (neutral).
MSFT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.1 | Neutral |
| Stochastic | 68.0 | Neutral |
MSFT's weekly RSI is 62 (neutral) and its Stochastic is 68 (neutral).
CPSH PE vs Technology Sector
| Metric | CPSH | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
CPSH has no meaningful PE right now: it lost money over the past year.
MSFT PE vs Technology Sector
| Metric | MSFT | Sector median | Relative |
|---|---|---|---|
| PE | 27x | 28x | 2% below |
| PE % | 16 | 35 | 19 pts below |
MSFT is trading at 27x earnings, in line with the Technology sector's median of 28x.
CPSH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.72 | 10% above |
| 20 week MA | $4.04 | 1.5% above |
| 50 week MA | $4.51 | 9.1% below |
| 100 week MA | $3.52 | 16% above |
| 200 week MA | $2.89 | 42% above |
CPSH's trend is mixed: it's above four of its five weekly moving averages, and 42% above its 200-week average.
MSFT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $524.7 | 0.3% below |
| 20 week MA | $484.8 | 7.9% above |
| 50 week MA | $446.9 | 17% above |
| 100 week MA | $453.8 | 15% above |
| 200 week MA | $411.5 | 27% above |
MSFT's trend is up, with a small recent dip: it's below only its 8-week average, and 27% above its 200-week average.
CPSH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.05 | $2.29 | +118% |
| 2021 | $2.29 | $4.34 | +90% |
| 2022 | $4.34 | $2.75 | -37% |
| 2023 | $2.75 | $2.35 | -15% |
| 2024 | $2.35 | $1.62 | -31% |
| 2025 | $1.62 | $3.21 | +98% |
| 2026 YTD | $3.21 | $4.10 | +28% |
CPSH has the edge over MSFT on returns for 2026, with the stronger performance.
MSFT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $159.0 | $222.8 | +40% |
| 2021 | $222.8 | $334.7 | +50% |
| 2022 | $334.7 | $238.7 | -29% |
| 2023 | $238.7 | $376.0 | +58% |
| 2024 | $376.0 | $430.5 | +14% |
| 2025 | $430.5 | $487.7 | +13% |
| 2026 YTD | $487.7 | $523.0 | +7.2% |
MSFT has finished higher in five of the last six years, two of them by more than 50%. It's up 7.2% so far in 2026.